These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6604513)

  • 21. Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis.
    Molina JM; Belenfant X; Doco-Lecompte T; Idatte JM; Modai J
    AIDS; 1991 May; 5(5):587-9. PubMed ID: 1863412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.
    Cohn JA; McMeeking A; Cohen W; Jacobs J; Holzman RS
    Am J Med; 1989 May; 86(5):521-7. PubMed ID: 2712059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acquired toxoplasmosis].
    Granz W
    Munch Med Wochenschr; 1967 Mar; 109(13):715-24. PubMed ID: 5631734
    [No Abstract]   [Full Text] [Related]  

  • 24. Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa.
    Beltrame A; Venturini S; Crichiutti G; Meroni V; Buonfrate D; Bassetti M
    Infection; 2016 Apr; 44(2):259-62. PubMed ID: 26168861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serologic evidence for acute toxoplasmosis in polymyositis-dermatomyositis. Increased frequency of specific anti-toxoplasma IgM antibodies.
    Magid SK; Kagen LJ
    Am J Med; 1983 Aug; 75(2):313-20. PubMed ID: 6349349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lympho-glandular toxoplasmosis. A diagnosis often missed.
    Lake KB; Van Dyke JJ; Abts RM; Moyes DR
    Postgrad Med; 1979 Jan; 65(1):110-2, 115-7. PubMed ID: 366587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute acquired toxoplasma encephalitis in an infant.
    Khanna KK; Singh M; Chowdhry P; Prakash O
    Can Med Assoc J; 1969 Feb; 100(7):343-5. PubMed ID: 5767078
    [No Abstract]   [Full Text] [Related]  

  • 28. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
    Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
    AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgE antibodies in toxoplasmosis.
    Matowicka-Karna J; Kemona H
    Postepy Hig Med Dosw (Online); 2014 May; 68():597-602. PubMed ID: 24864110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy of toxoplasmic encephalitis in AIDS patients.
    Filice G; Carnevale G; Orsolini P; Soldini L; Meroni V; Comolli G; Carenzo L
    J Chemother; 1989 Jul; 1(4 Suppl):949-50. PubMed ID: 16312718
    [No Abstract]   [Full Text] [Related]  

  • 31. Recognition and management of toxoplasmosis.
    Heitman BB; Irizarry AF
    Nurse Pract; 1997 Sep; 22(9):75, 79-82, 85-6 passim. PubMed ID: 9314166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Brain toxoplasmosis: from a case disclosing AIDS. Recall of diagnostic, developmental and therapeutic elements].
    Jourdan C; Guérin JM; Artru F; Lamy B; Grau A; Huppert J; Pialat J; Etienne J
    Neurochirurgie; 1986; 32(3):248-53. PubMed ID: 3762838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis.
    Stepick-Biek P; Thulliez P; Araujo FG; Remington JS
    J Infect Dis; 1990 Jul; 162(1):270-3. PubMed ID: 2192008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Juvenile dermatomyositis induced by toxoplasmosis.
    Schröter HM; Sarnat HB; Matheson DS; Seland TP
    J Child Neurol; 1987 Apr; 2(2):101-4. PubMed ID: 3598137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired toxoplasma encephalitis.
    Cottrell AJ
    Arch Dis Child; 1986 Jan; 61(1):84-5. PubMed ID: 3954425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxoplasmosis in the compromised host.
    Ruskin J; Remington JS
    Ann Intern Med; 1976 Feb; 84(2):193-9. PubMed ID: 766683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxoplasmosis: a treatable neurologic disease in the immunologically compromised patient.
    Emerson RG; Jardine DS; Milvenan ES; D'Souza BJ; Elfenbein GJ; Santos GW; Saral R
    Pediatrics; 1981 May; 67(5):653-5. PubMed ID: 7019842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.
    Dannemann B; McCutchan JA; Israelski D; Antoniskis D; Leport C; Luft B; Nussbaum J; Clumeck N; Morlat P; Chiu J
    Ann Intern Med; 1992 Jan; 116(1):33-43. PubMed ID: 1727093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Issues in toxoplasmosis.
    McCabe R; Chirurgi V
    Infect Dis Clin North Am; 1993 Sep; 7(3):587-604. PubMed ID: 8254161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sudden deafness and increased toxoplasmosis IgM titer].
    Schlottmann A; Kleemann D; Kranz K; Schmal G
    Laryngorhinootologie; 1996 Nov; 75(11):687-90. PubMed ID: 9063838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.